Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Michael Abramoff, EURETINA 2019 – AI-based diabetic retinopathy screening

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 19th 2019

AI was a hot topic at ESRCS 2019, so we were honoured to meet with Michael Abramoff (University of Iowa) to discuss his latest research around an autonomous AI diagnostic system to assist with the diagnosis of diabetic retinopathy.

Questions:
1. What are the limitations of current diagnosis of diabetic retinopathy? (0:04)
2. Could you tell us a little about the autonomous AI diagnostic system for diabetic retinopathy? (0:42)
3. What were the findings of your recent study evaluating this system? (1:29)
4. What is the current status of the system in Europe? (3:28)

Support: No funding was received in the production of this video.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup